ArticleClinical cancer drugs2017

UPFRONT DPD DEFICIENCY DETECTION TO SECURE 5-FU ADMINISTRATION: PART 2- APPLICATION TO HEAD-AND-NECK CANCER PATIENTS.

Manon Launay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.